Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 31.5B USD
- Positions
- 91
- Share of the ten largest
- 33.6%
The ten largest positions Q1 2025
- U.S. Bancorp 4.7%▲ +42.6%
- Charles Schwab Corporation 4.4%▲ +20.9%
- Bank of America 4.3%▲ +30.3%
- UnitedHealth Group 3.6%▲ +12.5%
- Intuit 3.3%▼ −0.7%
- Fortive 3.0%▼ −1.8%
- Meta Platforms 2.7%new
- Capital One 2.6%new
- Taiwan Semiconductor Manufacturing (ADR) 2.6%▲ +19.6%
- Api Group Corp 2.4%unchanged
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| INTU Intuit | 3.3% | 1,706,420 | 1.0B USD | −0.7% reduced | Q2 2024 4 quarters |
| FTV Fortive | 3.0% | 12,950,122 | 947.7M USD | −1.8% reduced | Q3 2019 23 quarters |
| Bridgebio Pharma Inc | 2.4% | 22,055,375 | 762.5M USD | −12.2% reduced | Q2 2019 24 quarters |
| V Visa Inc. | 2.4% | 2,125,091 | 744.8M USD | −39.2% reduced | Q3 2024 3 quarters |
| JPM JPMorgan Chase | 1.7% | 2,171,648 | 532.7M USD | −70.9% reduced | Q2 2024 4 quarters |
| PM Philip Morris International | 1.6% | 3,213,460 | 510.1M USD | −36.8% reduced | Q2 2023 8 quarters |
| Roivant Sciences Ltd | 1.5% | 46,013,752 | 464.3M USD | −3.8% reduced | Q4 2021 14 quarters |
| ALL Allstate | 1.1% | 1,703,403 | 352.7M USD | −12.1% reduced | Q2 2024 4 quarters |
| CPT Camden Property Trust | 1.1% | 2,788,789 | 341.1M USD | −17.1% reduced | Q1 2024 5 quarters |
| DASH DoorDash | 1.1% | 1,858,037 | 339.6M USD | −62.5% reduced | Q2 2024 4 quarters |
| Royalty Pharma PLC | 1.0% | 10,563,939 | 328.9M USD | −13.5% reduced | Q2 2020 20 quarters |
| PGR Progressive Corporation | 1.0% | 1,068,406 | 302.4M USD | −50.8% reduced | Q1 2022 13 quarters |
| SNPS Synopsys | 1.0% | 703,912 | 301.9M USD | −2.4% reduced | Q3 2024 3 quarters |
| MSFT Microsoft | 0.8% | 683,918 | 256.7M USD | −71.4% reduced | Q1 2024 5 quarters |
| AMT American Tower | 0.6% | 838,796 | 182.5M USD | −6.5% reduced | Q4 2024 2 quarters |
| MNST Monster Beverage | 0.5% | 2,857,800 | 167.2M USD | −64.6% reduced | Q4 2024 2 quarters |
| Transunion | 0.4% | 1,336,984 | 111.0M USD | −67.4% reduced | Q3 2024 3 quarters |
| Spotify Technology S A | 0.3% | 192,877 | 106.1M USD | −87.5% reduced | Q2 2024 4 quarters |
| Biontech SE | 0.3% | 879,972 | 80.1M USD | −6.5% reduced | Q3 2024 3 quarters |
| ADSK Autodesk | 0.3% | 304,494 | 79.7M USD | −59.8% reduced | Q3 2024 3 quarters |
| Travere Therapeutics Inc | 0.1% | 2,601,922 | 46.6M USD | −10.3% reduced | Q4 2024 2 quarters |
| APP AppLovin | 0.1% | 137,093 | 36.3M USD | −8.0% reduced | Q4 2024 2 quarters |
| TWLO Twilio | < 0.1% | 255,514 | 25.0M USD | −69.5% reduced | Q4 2024 2 quarters |
| Trevi Therapeutics Inc | < 0.1% | 3,227,792 | 20.3M USD | −26.6% reduced | Q3 2022 11 quarters |
| Immunovant Inc | < 0.1% | 1,114,827 | 19.1M USD | −20.8% reduced | Q1 2024 5 quarters |
| Edgewise Therapeutics Inc | < 0.1% | 490,035 | 10.8M USD | −60.0% reduced | Q1 2021 17 quarters |
| MET MetLife | < 0.1% | 84,312 | 6.8M USD | −98.6% reduced | Q3 2024 3 quarters |
| LI Li Auto | < 0.1% | 96,031 | 2.4M USD | −97.9% reduced | Q3 2024 3 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 26.2%
- Technology 11.5%
- Consumer Discretionary 11.4%
- Health Care 7.1%
- Industrials 6.4%
- Communication Services 6.3%
- Real Estate 2.3%
- Consumer Staples 2.2%
- Materials 1.1%
- not in our coverage 25.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors